Mr. Fares and others hold forth on a variety of topics and post links of interest.
Your opinion is welcome.
Your comments are subject to fair editorial review.
For the second quarter of the current financial year ending 30.09.11, Syngene had achieved a growth of 19% in revenue to Rs.93 crore over the previous quarter.Ongoing International CollaborationSyngene has ongoing collaboration agreements with sixty biotech and pharmaceutical companies at the international level. Copper also fetches money which results in much crime, sadly. We had both recently returned from the West.
1 Comments:
For the second quarter of the current financial year ending 30.09.11, Syngene had achieved a growth of 19% in revenue to Rs.93 crore over the previous quarter.Ongoing International CollaborationSyngene has ongoing collaboration agreements with sixty biotech and pharmaceutical companies at the international level. Copper also fetches money which results in much crime, sadly. We had both recently returned from the West.
Post a Comment
<< Home